Donald Jewell
Directeur/Bestuurslid bij Q5id, Inc.
Vermogen: 731 796 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Donald Jewell
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
Lantic, Inc. (Québec)
 Lantic, Inc. (Québec) Agricultural Commodities/MillingProcess Industries Lantic, Inc. refines, processes, distributes and markets sugar products. It includes Brown, Granulated, Liquid, Icing, Plantation Raw, Organic Sugar, Stevia, Syrups, Dry Blending, Jam & Jelly Mix products. The company was founded on June 30, 2008 and is headquartered in Montréal, Canada.
8
| Subsidiary | Agricultural Commodities/Milling | 8 |
Q5id, Inc.
 Q5id, Inc. Packaged SoftwareTechnology Services Q5id, Inc. provides identity management software solutions for enterprise and consumers. The company was founded by Steve Larson in April 2018 and is headquartered in Beaverton, OR.
7
| Holding Company | Packaged Software | 7 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA.
6
| Extinct | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Donald Jewell via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Chief Executive Officer | |
| ROGERS SUGAR INC. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Public Communications Contact | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Public Communications Contact Human Resources Officer | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Director/Board Member Chairman | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Public Communications Contact | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Operating Officer Sales & Marketing | |
Lantic, Inc.
 Lantic, Inc. Miscellaneous ManufacturingProducer Manufacturing Lantic, Inc. manufactures plastic products. The company was founded in 1999 and is headquartered in Foothill Ranch, CA. | Miscellaneous Manufacturing | Director/Board Member Sales & Marketing | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Queen's University | College/University | Graduate Degree Masters Business Admin | |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Medical Specialties | Director/Board Member Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| PERIMETER MEDICAL IMAGING AI, INC. | Medical Specialties | Director/Board Member Investor Relations Contact | |
| University of Western Ontario | College/University | Masters Business Admin Masters Business Admin | |
| University of Ottawa | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Doctorate Degree | |
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Eutropics Pharmaceuticals, Inc.
 Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Internet Software/Services | Founder Chief Operating Officer | |
| Georgetown University | College/University | Undergraduate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| CATALYST PAPER CORP. | Pulp & Paper | Chairman Director/Board Member | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| MONDELEZ INTERNATIONAL, INC. | Food: Specialty/Candy | Corporate Officer/Principal | |
| BALLARD POWER SYSTEMS INC. | Electrical Products | Director of Finance/CFO | |
VisCardia, Inc.
 VisCardia, Inc. Medical SpecialtiesHealth Technology VisCardia, Inc. develops and manufactures medical devices. The firm investigates a novel therapy for improving hemodynamic function to manage medical refractory heart failure. The company was founded in 2015 and is headquartered in Beaverton, OR. | Medical Specialties | Director/Board Member | |
Xantrex Technology, Inc.
 Xantrex Technology, Inc. SemiconductorsElectronic Technology Xantrex Technology, Inc. manufactures power supplies. It specializes in charger and inverter, power inverter, battery charger and backup power. The company is headquartered in Burnaby, Canada. | Semiconductors | Director of Finance/CFO |
Statistieken
Internationaal
| Canada | 29 |
| Verenigde Staten | 21 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 9 |
| Process Industries | 5 |
| Finance | 5 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 230 |
| Corporate Officer/Principal | 83 |
| President | 53 |
| Independent Dir/Board Member | 52 |
| Chief Executive Officer | 46 |
Sterkste connecties
| Insiders | |
|---|---|
| Ken Galbraith | 30 |
| Dan Kisner | 29 |
| Gary E. Frashier | 26 |
| R. MacKay-Dunn | 26 |
| Robert S. Whitehead | 22 |
| Ronald Ian Lennox | 22 |
| Richard King | 20 |
| M. Dallas Ross | 19 |
| Michael Jeffrey Abrams | 16 |
| Richard Henriques | 15 |
| Keith Manchester | 15 |
| Bruce Cousins | 14 |
| Paul Brennan | 14 |
| Michel P. Desbiens | 14 |
| Vivek Ramaswamy | 14 |
- Beurs
- Insiders
- Donald Jewell
- Bedrijfsconnecties
